Not Signed In - SRI International And Telik Announce Exclusive License For SRI To Develop Autoimmune And Inflammatory Disease Drug Candidate
Fri, 09 Feb 2007 08:00 AM EST
... SRI International, an independent nonprofit research and development organization, and Telik, Inc. (Nasdaq: TELK) today announced that they have signed an exclusive license agreement under which SRI will conduct preclinical studies of a Telik drug candidate for the treatment of multiple sclerosis and other autoimmune and inflammatory diseases. [click link for full article] ...
Related Topics
- Autoimmune Diseases
- Inflammatory Bowel Disease
- Sri Lanka
- Pelvic Inflammatory Disease
- Autoimmune Disorders
- International Health
- Crohn's Disease
- Liver Disease
- Autoimmune Liver Disease
- Autoimmune Hepatitis
- Pelvic Inflammatory Disease/pid
- Autoimmune Disease
- International Classification of Diseases
- Thyroid Diseases
- Drug Safety
- Prescription Drugs
- Confusion and changes in mental status may develop if the condition is not treated.
- Pelvic inflammatory disease (PID)
- Inflammatory Bowel Disease (IBD)
- Alzheimer's Disease
email this page
print this page
bookmark this page
feedback on this page
